Observational Study
Copyright ©The Author(s) 2023.
World J Transplant. Jun 18, 2023; 13(4): 183-189
Published online Jun 18, 2023. doi: 10.5500/wjt.v13.i4.183
Table 1 Study population, n (%)

Stroke
Traumatic brain injury
Postanoxic encelophaphy

Number 714819
Age (yr, mean ± SD)79 ± 1468 ± 2059 ± 190.0007a
Males34 (48)31 (65)10 (53)0.197b
Risk factors0.673b
Hypertension511024
Diabetes24916
Heart disease625
Refusals to donation131020.613b
Utilized donors (n)5435150.808b
Utilization rate (%)939289
Table 2 Haemodynamic data, n (%)

Stroke
Traumatic brain injury
Postanoxic encephalopathy

Number 71 (51)48 (35)19 (14)
ICU admission
SBP (mmHg), mean ± SD112 ± 44123 ± 3498 ± 330.002a
DBP (mmHg), mean ± SD74 ± 2174 ± 1877 ± 220.001a
HR (bpm), mean ± SD75 ± 2277 ± 3482 ± 350.015a
CVP (cmH2O), mean ± SD10 ± 311 ± 410 ± 30.819a
Norepinephrine31 (44)29 (60)14 (74)0.03b
Other vasoactive drugs5 (7)9 (18)6 (32)0.015b
Urine output, median (IQR)200 (125-393)261 (124-408)287 (186-440)0.279a
Lactate (mg/dL), median (IQR)1.5 (1-2.6)2.1 (1.3-3.1)1.8 (0.8-4.6)0.033a
Time 1
SBP (mmHg), mean ± SD123 ± 19125 ± 23122 ± 210.818a
DBP (mmHg), mean ± SD63 ± 1365 ± 1468 ± 170.497a
HR (bpm), mean ± SD86 ± 1692 ± 1794 ± 220.037a
Norepinephrine56 (78)43 (89)18 (95)0.120b
CVP (cmH2O), mean ± SD10 ± 311 ± 512 ± 70.001a
Other vasoactive drugs7 (9.8)10 (20)5 (26)0.113b
Urine output, median (IQR)113 (57-210)115 (85-285)110 (65 220)0.374a
Lactate (mg/dL), median (IQR)1.2 (0.9-1.7)1.4 (1-3.1)1.7 (1.3-3.1)0.006a
Time 2
SBP (mmHg), mean ± SD133 ± 25131 ± 22126 ± 270.510a
DBP (mmHg), mean ± SD66 ± 1465 ± 1270 ± 170.784a
HR (bpm), mean ± SD94 ± 1995 ± 1599 ± 250.760a
Norepinephrine5743180.172b
Other vasoactive drugs 8 (11)6 (12)5 (26)0.227b
CVP (cmH2O), mean ± SD10 ± 412 ± 4 (12)13 ± 40.040a
Urine output, median (IQR)143 (79-240)160 (95-250)200 (92-250)0.785a